Abbonarsi

Manchester Asthma and Allergy Study: Low-allergen environment can be achieved and maintained during pregnancy and in early life - 04/09/11

Doi : 10.1016/S0091-6749(00)90073-3 
Adnan Custovic, MD, Bridget M. Simpson, RN, Angela Simpson, MD, Claire Hallam, BSc, Mark Craven, MSc, Martin Brutsche, MD, Ashley Woodcock, MD
North West Lung Centre, Wythenshawe Hospital, Manchester, United Kingdom 

Abstract

Background: Early exposure to dust mite allergens may be critical for primary sensitization. Reducing exposure may offer a realistic chance for primary prevention of sensitization and asthma, but it is essential to implement measures that can achieve and maintain the low-allergen environment. Objective: Our purpose was to assess the effectiveness of mite allergen avoidance measures in achieving and maintaining a low-allergen environment during pregnancy and in the first year of life. Methods: The Manchester Asthma and Allergy Study is a prospective, prenatally randomized study that follows the development of asthma and atopy in a cohort of infants at high risk (both parents atopic) who are randomly allocated to full mite allergen avoidance or to a normal regimen. Avoidance measures comprise (1) mite-proof covers (mattress, pillow, and quilt) for parental bed, (2) high-filtration vacuum cleaner, (3) vinyl flooring in infant’s bedroom, (4) new crib and portable crib mattresses encased in mite-proof material, (5) benzyl benzoate (Acarosan) applied on carpets and soft furniture, (6) bed linens washed in hot water weekly, and (7) washable soft toys. Dust samples from the parental bed, bedroom floor, living room floor, infant’s mattress, and nursery floor were collected between the 10th and 14th weeks of pregnancy, immediately after birth, and then at age 6 months and 1 year, and Der p 1 levels were determined by mAb-based ELISA. Results: Recovered Der p 1 from maternal mattress was reduced by 97.25% (95% confidence interval [CI] 95.25%-98.41%) during the second and third trimesters of pregnancy, with the effect persisting for 6 months (98% reduction, 95% CI 97.25%-99.1%) and 12 months (97.6% reduction, 95% CI 95.7%-98.6%) after the birth (active vs control, P < .000001). Total Der p 1 from bedroom floor in the active group was reduced by 53.7% (95% CI 25.7%-71.2%) in samples collected within 4 weeks of the child’s birth, with the percentage reduction being 62.8% (95% CI 39.3%-77.2%) at 6 months and 26.5% (95% CI –24% to 57.1%) at 1 year (active compared vs control, P < .007). Der p 1 levels in crib mattress and nursery floor in the active group were extremely low (crib mattresses geometric mean [95% CI] 2.3 ng [1.6-3.4] at birth, 6.8 ng [4.5-10] at age 6 months, and 15.6 ng [9.8-24.8] at age 1 year [active vs control, P = .001]; nursery 1 ng [0.9-1.1] at birth, 1.7 ng [1.2-2.5] at age 6 months, and 2 ng [1.3-3.5] at age 1 year [active vs control, P < .00001]). The total amount of allergen recovered at age 1 year was 29-fold (95% CI 15.1- to 56.7-fold) higher in the control group than in the active group. Conclusions: The avoidance measures used in this study achieved and maintained a low mite allergen environment during pregnancy and in the first year of life in homes of infants at risk of atopy. (J Allergy Clin Immunol 2000;105:252-8.)

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Primary prevention, dust mite, avoidance, atopy, asthma

Abbreviations : BBS-T:, CI:, GM:, MAAS:


Mappa


 The Manchester Asthma and Allergy Study is supported by grants No. 301 and 362 from the National Asthma Campaign.
 Reprint requests: Adnan Custovic, MD, North West Lung Centre, Wythenshawe Hospital, Southmoor Road, Manchester M23 9LT, United Kingdom.
 0091-6749/2000 $12.00 + 0  1/1/103538


© 2000  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 105 - N° 2P1

P. 252-258 - Febbraio 2000 Ritorno al numero
Articolo precedente Articolo precedente
  • Evaluation of a short form for measuring health-related quality of life among pediatric asthma patients
  • Don A. Bukstein, Margaret M. McGrath, Deborah A Buchner, Jeanne Landgraf, Thomas F. Goss
| Articolo seguente Articolo seguente
  • Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma
  • David P. Skoner, Stanley J. Szefler, Michael Welch, Karen Walton-Bowen, Mario Cruz-Rivera, Joseph A. Smith

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.